Page last updated: 2024-08-24

gemcitabine and Lupus Erythematosus, Cutaneous, Subacute

gemcitabine has been researched along with Lupus Erythematosus, Cutaneous, Subacute in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Asada, H; Miyagawa, F; Sho, M; Sugano, Y1
Choi, JN; Subtil, A; Wiznia, LE1
Callen, JP1
Ben Shem, E; Ben Zvi, M; Levy, T; Menczer, J; Peled, O; Schreiber, L; Vaknine, H1

Reviews

1 review(s) available for gemcitabine and Lupus Erythematosus, Cutaneous, Subacute

ArticleYear
Subacute cutaneous lupus erythematosus induced by chemotherapy: gemcitabine as a causative agent.
    JAMA dermatology, 2013, Volume: 149, Issue:9

    Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Deoxycytidine; Drug Eruptions; Female; Gemcitabine; Humans; Lupus Erythematosus, Cutaneous

2013

Other Studies

3 other study(ies) available for gemcitabine and Lupus Erythematosus, Cutaneous, Subacute

ArticleYear
TS-1 (tegafur/gimeracil/oteracil)-induced systemic lupus erythematosus with skin lesions and anti-Sm antibody.
    European journal of dermatology : EJD, 2017, 12-01, Volume: 27, Issue:6

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Drug Therapy, Combination; Fluorouracil; Gemcitabine; Humans; Lupus Erythematosus, Cutaneous; Lupus Erythematosus, Systemic; Male; Oxonic Acid; Pancreatic Neoplasms; Pyridines; Renal Insufficiency; Tegafur

2017
Drug-induced subacute cutaneous lupus erythematosus--filling the gap in knowledge: comment on "subacute cutaneous lupus erythematosus induced by chemotherapy".
    JAMA dermatology, 2013, Volume: 149, Issue:9

    Topics: Antimetabolites, Antineoplastic; Deoxycytidine; Drug Eruptions; Female; Gemcitabine; Humans; Lupus Erythematosus, Cutaneous

2013
Gemcitabine-Induced Subacute Cutaneous Lupus Erythematosus: A Case Report.
    Chemotherapy, 2016, Volume: 61, Issue:5

    Topics: Administration, Oral; Anti-Inflammatory Agents; Antimetabolites, Antineoplastic; Deoxycytidine; Female; Gemcitabine; Humans; Lupus Erythematosus, Cutaneous; Lymph Nodes; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Prednisone; Skin; Treatment Outcome

2016